Jingjing Peng

Title: Innovations of Jingjing Peng in Pharmaceutical Science

Introduction

Jingjing Peng is a notable inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that target viral infections. Her work has led to the filing of multiple patents, showcasing her innovative approach to addressing critical health challenges.

Latest Patents

Jingjing Peng holds two recent patents that highlight her expertise. The first patent is for a ketoamide compound and its preparation method, along with a pharmaceutical composition and its use. This ketoamide compound is designed to effectively inhibit the coronavirus and Ebola virus, providing a potential method for the prevention or treatment of diseases related to these viruses. The second patent focuses on SARS-CoV-2 inhibitors for treating coronavirus infections, which includes compounds, pharmaceutical compositions, and methods aimed at combating SARS-CoV-2 infections.

Career Highlights

Throughout her career, Jingjing Peng has been associated with prestigious institutions such as the Chinese Academy of Sciences and Fudan University. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Jingjing has worked alongside notable colleagues, including Hong Tao Liu and Shibo Jiang. These collaborations have further enriched her research and innovation efforts in pharmaceutical sciences.

Conclusion

Jingjing Peng's contributions to the field of pharmaceutical science through her innovative patents demonstrate her commitment to addressing global health issues. Her work continues to pave the way for advancements in the treatment of viral infections.